Weiss Ratings Reiterates “Hold (C)” Rating for Option Care Health (NASDAQ:OPCH)

Option Care Health (NASDAQ:OPCH)‘s stock had its “hold (c)” rating reaffirmed by Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.

OPCH has been the subject of several other research reports. Cowen initiated coverage on shares of Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating for the company. Morgan Stanley initiated coverage on shares of Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price on the stock. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Tuesday, September 23rd. Finally, TD Cowen initiated coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating and a $30.00 target price on the stock. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.10.

Option Care Health Trading Down 0.5%

Shares of OPCH stock opened at $27.91 on Friday. Option Care Health has a 52-week low of $21.39 and a 52-week high of $35.53. The stock has a market cap of $4.53 billion, a price-to-earnings ratio of 22.33, a P/E/G ratio of 1.69 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The firm has a fifty day moving average of $27.99 and a 200-day moving average of $30.09.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.35 billion. During the same quarter in the prior year, the company posted $0.30 EPS. The business’s revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities research analysts forecast that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In other news, Director Norman L. Wright acquired 3,411 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The stock was purchased at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the acquisition, the director owned 15,501 shares in the company, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Timothy P. Sullivan acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The shares were purchased at an average price of $27.51 per share, with a total value of $550,200.00. Following the acquisition, the director owned 49,229 shares of the company’s stock, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 59,411 shares of company stock worth $1,627,576. 0.64% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. Durable Capital Partners LP lifted its stake in Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after buying an additional 4,720,988 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in Option Care Health by 30.8% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock valued at $146,947,000 after buying an additional 989,048 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Option Care Health by 109.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after buying an additional 1,778,279 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Option Care Health by 4.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock valued at $91,209,000 after buying an additional 99,574 shares in the last quarter. Finally, Norges Bank bought a new position in Option Care Health in the second quarter valued at approximately $69,932,000. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.